Propanc Biopharma Inc (OTCMKTS:PPCB)

Propanc Biopharma Inc (OTCMKTS:PPCB)


Share Price
$ 0.01
Change
0.0006 (9.68 %)
Market Cap
$2.86 m
Proactive Investors - Run By Investors For Investors

Propanc Biopharma Inc

Propanc Biopharma, Inc. (the “Company”) is a biopharmaceutical company developing new cancer treatments initially for patients suffering from pancreatic, ovarian and colorectal cancers.

EPIC: PPCB
Market: PPCB:PPCB
52-week High/Low: $0.289 / $0.004
Sector: Pharma & Biotech
Market Cap: $2.86 m
Website: www.propanc.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Propanc Biopharma Inc


Propanc Biopharma Inc Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use